Cannabis grower Tilray valued at up to US$1.5 billion for Nasdaq IPO

Cannabis, Life Science

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial, shares soar

Life Science

Amazon undercuts drugstores on prices for most over-the-counter drugs

Life Science

Apple reportedly won’t use Intel’s 5G modems in 2020 iPhones

Technology

The Trump administration could make fee-based doctors more affordable for seniors

Life Science

Sinovac Raises $86.73 Million Through Private Placement Transaction

Life Science

Amazon could start selling discounted meds to cash payers as soon as the PillPack deal closes

Life Science

Acceleron and Celgene Blood Disease Drug Luspatercept Hits The Mark in Phase III Trial

Life Science

Biogen Increases Ownership in Samsung Bioepis

Life Science

Zai Lab Starts Phase III China Trial of PARP Inhibitor

Life Science

Soligenix, Inc. Prices $8,000,000 Public Offering At The Market

Life Science

Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar

Life Science

China’s First Home-Developed Anti-Cancer Drug Deemed to Hit the Market by Year-End

Life Science

Chinese businesses make US firm’s most-valued companies list

Technology

Akebia and Keryx Merge to Become Leader in Therapies for Chronic Kidney Disease

Life Science